Patents Examined by Tekchand Saidha
  • Patent number: 11993799
    Abstract: A method for preparing a carbon source for wastewater treatment by using kitchen waste, comprises: adding a complex microbial inoculant into the kitchen waste; and phase-change degrading the kitchen waste into a phase-change liquid under aerobic fermentation of the complex microbial inoculant; wherein the phase-change liquid is the carbon source for wastewater treatment; the complex microbial inoculant comprises: a microbial agent comprising aerobic bacteria; and an excipient comprising an Fe-based MOF (metal-organic framework) nanocomposite. According to the method, the kitchen waste is treated under aerobic fermentation to prepare the carbon source, a carbon-nitrogen ratio is greater than 40, and the carbon source is used to supplement a carbon source in a sewage treatment process of a sewage plant, which significantly improves nitrogen and phosphorus removal effects of sewage treatment in the sewage plant, and provides theoretical foundation and basis for resource utilization of the kitchen waste.
    Type: Grant
    Filed: November 1, 2023
    Date of Patent: May 28, 2024
    Assignee: HANGZHOU NANDA ENVIRONMENTAL PROTECTION TECHNOLOGY CO., LTD
    Inventors: Jianlin Xu, Bin Gu, Yuan Fu, Zhenggeng Qiu
  • Patent number: 11993635
    Abstract: This invention relates to the field of genetic engineering. Specifically, the invention relates to the construction of operons to produce biologically active agents. For example, operons may be constructed to produce agents that control the function of biochemical pathway proteins (e.g., protein phosphatases, kinases and/or proteases). Such agents may include inhibitors and modulators that may be used in studying or controlling phosphatase function associated with abnormalities in a phosphatase pathway or expression level. Fusion proteins, such as light activated protein phosphatases, may be genetically encoded and expressed as photoswitchable phosphatases. Systems are provided for use in controlling phosphatase function within living cells or in identifying small molecule inhibitors/activator/modulator molecules of protein phosphatases associated with cell signaling.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: May 28, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Jerome Fox, Ankur Sarkar, Akarawin Hongdusit, Edward Kim
  • Patent number: 11987602
    Abstract: The methods and systems disclose enzymes that function to import malonic acid or malonates into a cell. The enzymes increase the output of precursor molecules by enriching certain pathways in the cell. The precursor molecules can be converted to cannabinoids. The enzymes are a family of proteins which have a majority of common alignments.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: May 21, 2024
    Assignee: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Jacob Michael Vogan
  • Patent number: 11987833
    Abstract: The present invention relates to a novel enzyme capable of producing multi-hydroxy derivatives from polyunsaturated fatty acids and a method for producing multi-hydroxy derivatives of polyunsaturated fatty acids using the same.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: May 21, 2024
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Jeong Woo Seo, Jong Jae Yi, Sun Yeon Heo, Young Bae Kim, Chul Ho Kim, Baek Rock Oh, Jung Hyun Ju, Hack Sun Choi
  • Patent number: 11981709
    Abstract: The present invent in discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: May 14, 2024
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng, Stanislaw Flasinski
  • Patent number: 11981947
    Abstract: The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: May 14, 2024
    Assignee: Chr. Hansen HMO GmbH
    Inventor: Stefan Jennewein
  • Patent number: 11981941
    Abstract: The present invention relates to polypeptides, nucleotides encoding the polypeptide, as well as methods of producing the polypeptides. The present invention also relates to detergent composition comprising polypeptides, a laundering method and the use of polypeptides.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: May 14, 2024
    Assignee: NOVOZYMES A/S
    Inventors: Morten Gjermansen, Klaus Gori, Henrik Marcus Geertz-Hansen, Jesper Salomon, Thomas Holberg Blicher, Nikolaj Spodsberg
  • Patent number: 11970520
    Abstract: An expression vector is provided for production of human alpha-synuclein (?S) protein or a conservative variant thereof that exhibits a decreased tendency to self-aggregate in an ?S seed amplification assay (SAA). The expression vector comprises a nucleic acid sequence coding for human ?S protein or a conservative variant, the nucleic acid sequence comprising codons that have been optimized to produce human ?S protein or a conservative variant when expressed by a host cell such as E. coli. The codons have been optimized to avoid amino acid misincorporation in the expressed protein. Methods for purification of the expressed protein are also provided.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: April 30, 2024
    Assignee: Amprion, Inc.
    Inventors: Luis Concha, Carly Farris, Bret Holguin, Yihua Ma
  • Patent number: 11969717
    Abstract: The present disclosure provides a method for preparing an organophosphorus degrading enzyme based multifunctional catalyst and an organophosphorus degrading enzyme based multifunctional catalyst and use thereof. In the present disclosure, the preparation method includes: directly adding a composite yolk-shell-structured nanomaterial into a crude enzyme solution of organophosphorus degrading enzyme with an affinity tag, and mixing, to obtain a mixture, and then subjecting the mixture to a separation, to obtain an organophosphorus degrading enzyme based multifunctional catalyst.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: April 30, 2024
    Assignee: Hebei University of Technology
    Inventors: Yanjun Jiang, Liya Zhou, Saiguang Xue, Jing Gao
  • Patent number: 11970722
    Abstract: The present invention provides engineered acid alpha-glucosidase (GAA) polypeptides and compositions thereof. In some embodiments, the engineered GAA polypeptides have been optimized to provide increased expression, stability at neutral pH, and activity in cell lysates. The invention also provides methods for utilization of the compositions comprising the engineered GAA polypeptides for therapeutic and other purposes.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: April 30, 2024
    Assignee: Codexis, Inc.
    Inventors: William Casey Hallows, Rachel Cathleen Botham, Yu Zhu, Chinping Chng, Nikki Dellas, Gjalt W. Huisman, Moulay Hicham Alaoui Ismaili, David William Homan, Adam P. Silverman, Jonathan Vroom, Jessica P. Lao
  • Patent number: 11965203
    Abstract: Embodiments of the invention relate generally to methods to generate microorganisms and/or microorganism cultures that exhibit the ability to produce polyhydroxyalkanoates (PHA) from carbon sources at high efficiencies. In several embodiments, preferential expression of, or preferential growth of microorganisms utilizing certain metabolic pathways, enables the high efficiency PHA production from carbon-containing gases or materials. Several embodiments relate to the microorganism cultures, and/or microorganisms isolated therefrom.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: April 23, 2024
    Assignee: Newlight Technologies, Inc.
    Inventor: Markus D. Herrema
  • Patent number: 11952558
    Abstract: The present invention relates to novel protease variants exhibiting improved stability and or improved wash performance in liquid detergent. The variants of the invention are suitable for use in e.g. cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions. The present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention.
    Type: Grant
    Filed: April 6, 2021
    Date of Patent: April 9, 2024
    Assignee: NOVOZYMES A/S
    Inventors: Miguel Duarte Guilherme Pereira Toscano, Esben Peter Friis, Rolf Thomas Lenhard, Signe Eskildsen Larsen, Astrid Munch, Bena-Marie Lue, Mikael Bauer
  • Patent number: 11950618
    Abstract: Provided are dry-milling methods for producing an aqueous fermentation feedstock ingredient. The methods include providing a corn-processing filtration feed; filtering at least a fraction of said filtration feed on a microfiltration membrane, whereby an aqueous filtration permeate and a filtration retentate are formed; separating said filtration permeate from said filtration retentate, to form separated permeate and separated retentate; forming a fermentation feedstock comprising said separated permeate, and saccharifying and/or washing said separated retentate.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: April 9, 2024
    Assignees: SUPERBREWED FOOD INC., AdvanceBio, LLC
    Inventors: Bryan P. Tracy, Dale A. Monceaux
  • Patent number: 11952607
    Abstract: The disclosure provides genetically engineered microorganisms and methods for improved biological production of ethylene glycol and precursors of ethylene glycol. The microorganism of the disclosure produces ethylene glycol or a precursor of ethylene glycol through one or more of 5,10-methylenetetrahydrofolate, oxaloacetate, citrate, malate, and glycine. The disclosure further provides compositions comprising ethylene glycol or polymers of ethylene glycol such as polyethylene terephthalate.
    Type: Grant
    Filed: August 5, 2022
    Date of Patent: April 9, 2024
    Assignee: LanzaTech, Inc.
    Inventors: Zachary Robert Cowden, Ching Leang, Michael Koepke, Rasmus Overgaard Jensen, Alexander Paul Mueller
  • Patent number: 11946078
    Abstract: Disclosed herein are cellulase variants, or active fragments thereof, and polynucleotides encoding same, where the cellulase variants, or active fragments thereof, have endoglucanase activity. Also disclosed herein are compositions comprising the cellulase variants, or active fragments thereof; vectors and/or host cells comprising the polynucleotides encoding the cellulase variants, or active fragments thereof; and methods for making and/or using the cellulase variants, or active fragments thereof and/or compositions containing same; where the cellulase variants, or active fragments thereof, have endoglucanase activity.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: April 2, 2024
    Assignee: Danisco US Inc.
    Inventors: Neeraj Pandey, Sina Pricelius, Annapurna Sachan, Stepan Shipovskov, Richard Bott, Ajit Kumar Satapathy
  • Patent number: 11939557
    Abstract: The present disclosure concerns recombinant yeast host cells expressing heterologous enzymes for hydrolyzing flavor compounds glycosidically bound to a sugar molecule. The recombinant yeast host cells can be used in a subsequent production process to make alcoholic beverage products such as wines and beers.
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: March 26, 2024
    Assignee: Danstar Ferment AG
    Inventors: Charles F. Rice, Aaron Argyros
  • Patent number: 11939618
    Abstract: The present invention provides for a fusion protein comprising: (a) a terpene synthase (TS), or a homolog thereof, (b) a peptide linker, and (c) a P450 enzyme, or a homolog thereof.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: March 26, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Taek Soon Lee, Xi Wang
  • Patent number: 11926858
    Abstract: The invention relates to a genetically modified microorganism for making a oligosaccharide, preferably of 3-8 monosaccharide units, more preferably of 3-5 monosaccharide units, particularly a HMO, which comprises one or more genes encoding a sucrose utilization system, so the microorganism can use sucrose as a carbon and energy source.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: March 12, 2024
    Assignee: GLYCOM A/S
    Inventors: Margit Pedersen, Manos Papadakis, Peter Becker, Eric Samain, Pauline Peltier-Pain, Katrine Bych, Ted Johanson, Elise Champion, Gyula Dekany
  • Patent number: 11925193
    Abstract: A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto. A recombinant host capable of producing a steviol glycoside which has been modified, preferably in its genome, to result in a deficiency in the production of a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: March 12, 2024
    Assignee: DSM IP Assets B.V.
    Inventors: Viktor Marius Boer, Priscilla Zwartjens, Eric Van Den Berg
  • Patent number: 11918633
    Abstract: Phenylalanine ammonia-lyase (PAL) variants with a greater phenylalanine-converting activity and/or a reduced immunogenicity as compared to a wild-type PAL for therapeutic uses, including the treatment of adolescent subjects having PKU.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: March 5, 2024
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventor: Debra Lounsbury